How to buy USANA Health Sciences shares | $101.695

Own USANA Health Sciences shares in just a few minutes. Share price changes are updated daily.

USANA Health Sciences, Inc (USNA) is a leading household and personal products business based in the US. It opened the day at $101.74 after a previous close of $102.84. During the day the price has varied from a low of $101.285 to a high of $102.54. The latest price was $101.695 (25 minute delay). USANA Health Sciences is listed on the NYSE and employs 1,943 staff. All prices are listed in US Dollars.

How has coronavirus impacted USANA Health Sciences's share price?

Since the stock market crash that started in February 2020, USANA Health Sciences's share price has had significant positive movement.

Its last market close was $105.3, which is 33.09% up on its pre-crash value of $70.46 and 144.83% up on the lowest point reached during the March 2020 crash when the shares fell as low as $43.01.

If you had bought $1,000 worth of USANA Health Sciences shares at the start of February 2020, those shares would have been worth $798.42 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,671.11.

USANA Health Sciences share price

Use our graph to track the performance of USNA stocks over time.

USANA Health Sciences shares at a glance

Information last updated 2021-06-18.
Open$101.74
High$102.54
Low$101.285
Close$101.695
Previous close$102.84
Change $-1.145
Change % -1.1134%
Volume 30,740
Information last updated 2021-06-17.
52-week range$68.3 - $107.85
50-day moving average $100.6263
200-day moving average $92.2297
Wall St. target price$115
PE ratio 16.8924
Dividend yield N/A (0%)
Earnings per share (TTM) $6.085
Promoted
eToro Free Stocks

Invest in USANA Health Sciences shares with 0% commission

Other fees apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • Pay no stamp duty on UK shares (saving 0.5%)
  • Create an account today in a few minutes

Share dealing platform comparison

Table: sorted by promoted deals first
Name Product Ratings Finder rating Customer rating Min. initial deposit Price per trade Frequent trader rate Platform fee Offer Link
Hargreaves Lansdown Fund and Share Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£1
£11.95
£5.95
£0

Capital at risk

Platform details
FREE TRADES
eToro Free Stocks
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
$200
£0
N/A
£0

Capital at risk

Platform details
FREE TRADES
Stake
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£50
US: £0
N/A
£0
Join and receive a free share worth up to £100

Capital at risk

Platform details
Degiro Share Dealing
Finder score
★★★★★
★★★★★
Expert analysis
Not yet rated
£0.01
UK: £1.75 + 0.014% (max £5)
US: €0.50 + $0.004 per share
N/A
£0

Capital at risk

Platform details
interactive investor Trading Account
Finder score
★★★★★
User survey
★★★★★
★★★★★
Expert analysis
★★★★★
User survey
£0
£7.99 (with one free trade per month)
N/A
£9.99 per month

Capital at risk

Platform details
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy USANA Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

USANA Health Sciences price performance over time

Historical closes compared with the last close of $101.695

1 week (2021-06-08) -1.56%
1 month (2021-05-18) 1.36%
3 months (2021-03-18) 3.26%
6 months (2020-12-18) 28.94%
1 year (2020-06-18) 28.42%
2 years (2019-06-18) 36.58%
3 years (2018-06-18) -14.51%
5 years (2016-06-17) 80.90%

Is USANA Health Sciences under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

P/E ratio

USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, USANA Health Sciences shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

PEG ratio

USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A PEG ratio close to 1 can be interpreted as meaning shares offer reasonable value for the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $195.2 million.

The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.

Financials

Revenue TTM $1.2 billion
Operating margin TTM 15.45%
Gross profit TTM $925.5 million
Return on assets TTM 21.46%
Return on equity TTM 35.74%
Profit margin 10.95%
Book value $19.723
Market capitalisation $2.1 billion

TTM: trailing 12 months

How to short and sell USANA Health Sciences shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "USNA.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 615,994 USANA Health Sciences shares held short by investors – that's known as the "short interest". This figure is 5.1% down from 649,200 last month.

There are a few different ways that this level of interest in shorting USANA Health Sciences shares can be evaluated.

Short interest ratio (SIR)

USANA Health Sciences's "short interest ratio" (SIR) is the quantity of USANA Health Sciences shares currently shorted divided by the average quantity of USANA Health Sciences shares traded daily (recently around 111593.11594203). USANA Health Sciences's SIR currently stands at 5.52. In other words for every 100,000 USANA Health Sciences shares traded daily on the market, roughly 5520 shares are currently held short.

However USANA Health Sciences's short interest can also be evaluated against the total number of USANA Health Sciences shares, or, against the total number of tradable USANA Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case USANA Health Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 USANA Health Sciences shares in existence, roughly 30 shares are currently held short) or 0.0578% of the tradable shares (for every 100,000 tradable USANA Health Sciences shares, roughly 58 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against USANA Health Sciences.

Find out more about how you can short USANA Health Sciences stock.

USANA Health Sciences share dividends

We're not expecting USANA Health Sciences to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have USANA Health Sciences's shares ever split?

USANA Health Sciences's shares were split on a 2:1 basis on 23 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.

Share price volatility

Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $68.3 up to $107.85. A popular way to gauge a stock's volatility is its "beta".

USNA.US volatility(beta: 0.92)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.9201. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked
Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site